Christine Surka
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Protein Degradation and Inhibitors, RNA Research and Splicing, Multiple Myeloma Research and Treatments, RNA modifications and cancer
Most-Cited Works
- → Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)(2016)1,550 cited
- → The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3(2015)1,216 cited
- → RNA-RNA Interactions Enable Specific Targeting of Noncoding RNAs to Nascent Pre-mRNAs and Chromatin Sites(2014)500 cited
- → Simultaneous generation of many RNA-seq libraries in a single reaction(2015)315 cited
- → Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing(2016)277 cited
- → CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells(2020)213 cited
- → Replisome stalling and stabilization at CGG repeats, which are responsible for chromosomal fragility(2009)122 cited
- → UBE2G1 governs the destruction of cereblon neomorphic substrates(2018)73 cited
- → The Xist lncRNA Exploits Three-Dimensional Genome Architecture to Spread Across the X Chromosome(2013)61 cited
- → CC-92480 Is a Novel Cereblon E3 Ligase Modulator with Enhanced Tumoricidal and Immunomodulatory Activity Against Sensitive and Resistant Multiple Myeloma Cells(2019)21 cited